Procter & Gamble Health shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters51.82%no change
Foreign investors (FII)6.42%+0.09 pts
Domestic institutions (DII)12.63%+0.19 pts
of which mutual funds8.89%−0.16 pts
of which insurance companies3.63%
Public29.13%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHL₹5,399.00

Procter & Gamble Health Limited

· Pharma & Health
₹ CrorePeersSANOFICONRSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹8,962 Cr
Holding % of Total Shares
12 Months Ending
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group51.8251.8251.8251.8251.8251.8251.8251.8251.8251.82
FII / FPI6.406.617.026.876.997.246.976.206.336.42
DII14.5514.8414.7114.2114.1613.9113.8413.6712.4412.63
Mutual Funds10.1910.4510.6410.5410.6510.5610.4810.209.058.89
Latest: 2026-09-30 · 21 quarters of history · click a row to chart it.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.